Testing genetic samples in pregnancy to check chromosome changes
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study collects genetic samples from pregnant people who have a higher chance of chromosome changes in the baby. It tests whether taking samples through CVS and/or amniocentesis can help understand the baby’s genetic makeup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 22 weeks pregnant
- You are 18 years old or older
- You can give signed consent to join the study
- Your pregnancy is considered higher risk for chromosome (aneuploidy) changes
- You are willing to have CVS and/or amniocentesis for genetic testing
- You agree to receive the genetic results from the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test that looks for fetal cells in your bloodstream to check your baby's health during pregnancy. The test is non-invasive—just a regular blood draw—and aims to help identify pregnancy risks earlier than traditional methods.
This study tests a new blood test that can screen for genetic problems in babies during pregnancy. It may find more conditions than standard tests, especially for pregnancies with certain ultrasound findings or other risk factors.
This study looks at the benefits of doing extra genetic testing (genomic sequencing) on samples from routine prenatal tests like CVS or amniocentesis, specifically for pregnancies where the baby appears normal on ultrasound.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This study tests a safer blood test to check for certain genetic disorders during pregnancy, instead of an invasive procedure like amniocentesis. It's for pregnant women who are at risk of passing on a known genetic condition.
This study tests a new way to find genetic causes of congenital heart disease (a heart problem found before birth) using samples from amniocentesis or chorionic villus sampling. It may help parents get a clearer diagnosis and plan for their baby's care.
Hear when a new Down Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.